Emergent BioSolutions | Fremdkapital



Loan Capital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
ALKERMES USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Amarin USD 0 0 2025-03
ANI Pharmaceuticals USD 611.63M 3.29M 2025-03
BioMarin Pharmaceutical USD 595.65M 244K 2025-03
Exact Sciences USD 2.33B 693K 2025-03
Exelixis USD 0 0 2025-04
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Lonza CHF 4.24B 602M 2024-12
Merck USD 33.48B 978M 2025-03
Moderna USD 35M 4M 2025-03
Myriad Genetics USD 59.3M 19.7M 2025-03
Neurocrine Biosciences USD 0 0 2024-12
Pacira USD 381.29M 2.26M 2025-03
Pfizer USD 57.64B 234M 2025-03
PTC Therapeutics USD 2.12B 179K 2024-12
Sanofi 13.41B 1.62B 2025-03
Sarepta Therapeutics USD 1.14B 1.16M 2025-03
United Therapeutics USD 0 0 2025-03



Emergent BioSolutions Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.